Benzinga - U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
- Entrada Therapeutics Inc (NASDAQ: TRDA) shares dipped 33.5% to $13.22 after the company said it received a clinical hold notice from the FDA regarding its Investigational New Drug Application for ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy.
- Arcus Biosciences, Inc. (NYSE: RCUS) declined 28.1% to $21.92. Gilead Sciences (NASDAQ:GILD) and Arcus Biosciences announced results from the fourth interim analysis of the ARC-7 Phase 2 study for metastatic non-small cell lung cancer with PD-L1 tumor proportion score ≥50% without epidermal growth factor receptor or anaplastic lymphoma kinase mutations.
- BioVie Inc. (NASDAQ: BIVI) declined 27% to $7.27.
- Embecta Corp. (NASDAQ: EMBC) dropped 14.8% to $27.65 after the company reported a decline in Q4 sales.
- Vigil Neuroscience, Inc. (NASDAQ: VIGL) dropped 14.5% to $10.51.
- Mullen Automotive, Inc. (NASDAQ: MULN) declined 14.1% to $0.2330.
- FuelCell Energy, Inc. (NASDAQ: FCEL) fell 13.8% to $2.81 after the company reported worse-than-expected Q4 EPS and sales results.
- iTeos Therapeutics, Inc. (NASDAQ: ITOS) dropped 13.2% to $17.05.
- Ark Restaurants Corp. (NASDAQ: ARKR) fell 13.1% to $15.74 after the company reported a sharp decline in quarterly earnings.
- Summit Therapeutics Inc. (NASDAQ: SMMT) dropped 12.8% to $3.7707.
- Embecta Corp. (NASDAQ: EMBC) fell 12.4% to $28.47 after the company reported Q4 earnings results.
- ioneer Ltd (NASDAQ: IONR) dropped 12.3% to $11.96.
- Terns Pharmaceuticals, Inc. (NASDAQ: TERN) fell 10.5% to $8.01 after the company announced a proposed $75 million public offering.
- Century Therapeutics, Inc. (NASDAQ: IPSC) declined 9.5% to $6.31.
- Horizon Technology Finance Corporation (NASDAQ: HRZN) fell 8.3% to $11.02 after Keefe, Bruyette & Woods downgraded the stock from Market Perform to Underperform and lowered its price target from $11.5 to $10.5.
- Sintx Technologies, Inc. (NASDAQ: SINT) dropped 7% to $7.25. Sintx Technologies announced a 1-for-100 reverse stock split, effective December 20, 2022.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.